Saturday 17 October 2026
Export GDRX’s income statement to Excel — free account
GoodRx Holdings, Inc.
GDRX Healthcare Health Information Services
GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 1.31%, EPS fell 25.0%, free cash flow grew 112.5% and total debt was flat, each against the same quarter a year earlier.
3.36
0.15
−4.27%
Follow GDRX
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 4 | 4 | 3 | 5 | 8 | 6 |
P/E ratio |
138.66 | 138.66 | 138.66 | 138.66 | 0.00 | 0.00 | 0.00 | 0.00 | 98.10 | 30.04 |
Altman Z-Score |
— | — | — | — | 8.03 | 10.37 | 1.31 | 1.69 | 1.36 | 0.44 |
P/S ratio |
24.64 | 24.64 | 24.64 | 24.64 | 20.12 | 17.97 | 2.54 | 3.07 | 2.26 | 1.21 |
Altman Z″-Score (non-manufacturers) |
— | — | (9.82) | (6.41) | 1.22 | 2.42 | 1.60 | 0.96 | 0.61 | (0.18) |
P/FCF ratio |
75.95 | 75.95 | 75.95 | 75.95 | 116.01 | 92.84 | 21.24 | 27.94 | 15.80 | 10.29 |
Beneish M-Score |
— | — | — | (2.19) | (3.66) | (2.33) | (2.86) | (2.70) | (2.94) | (2.40) |
P/Operating CF |
304.01 | 304.01 | 304.01 | 304.01 | 746.21 | 268.99 | 61.00 | 145.32 | 40.09 | 29.36 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 15.58 | 16.11 | 2.39 | 3.03 | 2.48 | 1.57 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 26.81 | 32.43 | 6.88 | 7.94 | 6.85 | 7.92 |
EV/Sales |
25.93 | 25.93 | 25.93 | 25.93 | 19.57 | 17.60 | 2.41 | 3.05 | 2.32 | 1.50 |
EV/EBITDA |
70.22 | 70.22 | 70.22 | 70.22 | 0.00 | 255.30 | 31.12 | 27.25 | 13.32 | 6.83 |
EV/Operating CF |
73.20 | 73.20 | 73.20 | 73.20 | 82.05 | 73.39 | 12.58 | 16.56 | 9.99 | 7.10 |
EV/FCF |
79.93 | 79.93 | 79.93 | 79.93 | 112.82 | 90.91 | 20.16 | 27.75 | 16.18 | 12.70 |
Quick Ratio |
0.00 | 0.00 | 4.09 | 2.22 | 17.47 | 13.06 | 11.46 | 6.66 | 4.80 | 2.02 |
Current Ratio |
— | — | 4.40 | 2.59 | 18.24 | 13.42 | 12.05 | 7.12 | 5.32 | 2.61 |
Net Debt/EBITDA |
0.79 | 1.99 | 7.79 | 4.12 | 1.20 | (5.41) | (1.66) | (0.19) | 0.31 | 1.30 |
Debt/Assets |
15.54% | 0.00% | 229.43% | 173.46% | 45.36% | 41.23% | 41.06% | 41.32% | 35.42% | 34.78% |
Debt/Equity |
5.75 | (1.58) | (1.70) | (1.91) | 0.94 | 0.80 | 0.81 | 0.86 | 0.68 | 0.79 |
Asset Turnover |
0.34 | 1.06 | 0.82 | 1.11 | 0.59 | 0.48 | 0.48 | 0.47 | 0.53 | 0.57 |
Operating CF/Net income |
0.00 | 0.00 | 3.18 | 1.95 | (0.45) | (7.08) | (4.47) | (15.59) | 11.22 | 5.52 |
Capex/Depreciation |
— | — | (0.31) | (0.34) | (1.64) | (0.91) | (0.96) | (0.50) | (0.98) | (0.85) |
Interest Coverage |
10.62 | 14.39 | 3.48 | 2.82 | (9.88) | 0.57 | 0.05 | (0.48) | 1.24 | 2.05 |
| 3.77% | (4.29%) | (2.01%) | (3.80%) | 156.09% | (3.27%) | (3.99%) | (1.12%) | 2.21% | 4.54% | |
| (2.67%) | 5.98% | 4.66% | 12.19% | (31.62%) | (1.64%) | (2.04%) | (0.56%) | 1.10% | 2.18% | |
ROIC |
0.00% | 0.00% | 18.41% | 29.66% | (42.37%) | 1.51% | 0.15% | (2.26%) | 5.36% | 6.49% |
Return on Tangible Assets |
0.00% | 0.00% | 24.77% | 77.62% | (27.97%) | (2.45%) | (3.80%) | (1.16%) | 2.99% | 7.44% |
Average Days of Receivables |
0.00 | 0.00 | 48.80 | 45.25 | 45.55 | 57.82 | 55.78 | 69.86 | 67.23 | 107.98 |
Research and Development Expense of Revenue |
5.78% | 7.31% | 17.59% | 7.55% | 11.22% | 16.88% | 18.67% | 18.11% | 15.62% | 15.19% |
Selling, General and Administrative Expense of Revenue |
64.80% | 52.95% | 45.10% | 49.37% | 130.12% | 70.42% | 65.54% | 62.22% | 61.21% | 55.91% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.75 | 0.67 | 0.20 | 0.26 | 0.33 | 0.30 | 0.33 | 0.35 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.71% | 0.97% | 72.14% | 21.53% | 15.69% | 13.97% | 12.50% | 9.62% |
Graham Net Nets |
0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.07 | 0.02 | 0.00 | (0.15) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.42 | 1.87 |
Earnings Yield |
0.72% | 0.72% | 0.72% | 0.72% | (2.66%) | (0.17%) | (1.66%) | (0.32%) | 1.02% | 3.33% |
Free Cash Flow Yield |
1.32% | 1.32% | 1.32% | 1.32% | 0.86% | 1.08% | 4.71% | 3.58% | 6.33% | 9.72% |
Revenue per Share |
0.26 | 0.41 | 2.23 | 1.71 | 2.00 | 1.82 | 1.86 | 1.83 | 2.05 | 2.24 |
Operating CF per Share |
0.00 | 0.00 | 0.40 | 0.37 | 0.48 | 0.44 | 0.36 | 0.34 | 0.48 | 0.47 |
Capex per Share |
0.00 | 0.00 | (0.03) | (0.03) | (0.13) | (0.08) | (0.13) | (0.14) | (0.18) | (0.21) |
Free Cash Flow per Share |
0.00 | 0.00 | 0.37 | 0.34 | 0.35 | 0.35 | 0.22 | 0.20 | 0.29 | 0.26 |
Cash per Share |
0.06 | 0.05 | 0.31 | 0.12 | 3.54 | 2.30 | 1.83 | 1.64 | 1.16 | 0.73 |
Shareholders Equity per Share |
0.02 | (0.22) | (3.80) | (1.55) | 2.59 | 2.03 | 1.97 | 1.86 | 1.88 | 1.73 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.02 | (0.22) | (3.80) | (1.55) | 2.59 | 2.03 | 1.97 | 1.86 | 1.88 | 1.73 |
Free Cash Flow |
— | — | 41.80 | 77.54 | 95.52 | 144.32 | 91.57 | 82.53 | 113.55 | 93.88 |
Working Capital |
— | — | 56.45 | 53.21 | 1,026.82 | 1,007.71 | 843.37 | 750.23 | 535.35 | 397.10 |
Capital Expenditures |
— | — | (3.46) | (5.75) | (35.82) | (34.46) | (55.21) | (55.77) | (70.35) | (74.02) |
Net Current Asset Value |
(46.00) | (136.00) | (667.14) | (650.79) | 327.61 | 312.88 | 129.88 | 45.95 | (4.15) | (144.69) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 978.66 | 1,062.27 | 0.00 | 27.90 | 13.63 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.01 | 0.07 | 0.05 | 0.07 | 0.07 | 0.09 | 0.09 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 999.42 | 1,118.85 | 0.00 | 27.24 | 11.04 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
— | — | 11.18 | 9.12 | 0.95 | 1.76 | 2.91 | 6.97 | 5.69 | 7.09 |
Cash ROIC |
0.00% | 0.00% | 12.61% | 22.38% | 4.06% | 5.93% | 4.10% | 3.95% | 6.82% | 6.87% |
Accounts Receivable Turnover |
0.00 | 0.00 | 6.16 | 9.53 | 9.43 | 7.98 | 6.52 | 5.75 | 5.47 | 4.18 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.80 | 1.86 | 3.26 | 3.36 | 3.70 | 2.48 | 1.91 | 3.43 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 435.46 | 204.45 | 126.95 | 136.74 | 99.27 | 197.79 | 107.02 | 122.97 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 40.50 | 40.74 | 58.43 | 93.40 | 117.61 | 130.37 | 144.77 | 190.84 |
Average Payables |
— | — | 7.50 | 7.53 | 9.07 | 13.90 | 17.60 | 26.98 | 25.20 | 16.77 |
Average Assets |
291.50 | 148.00 | 305.40 | 350.79 | 928.46 | 1,538.87 | 1,606.13 | 1,596.72 | 1,488.43 | 1,396.06 |
Average Common Equity |
(206.00) | (206.00) | (707.71) | (1,125.00) | (188.11) | 771.52 | 823.25 | 788.39 | 743.31 | 670.46 |
Columns are period end dates